Research Article

Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease

Table 7

Multivariate analysis of risk factors that hinder improvement in platelet count.

ComparisonOdds ratio (95%C.I) value

Baseline total bilirubin (mg/dl)Per increase in the level5.93 (1.15-30.50)≤0.033
Baseline albumin (g/dl)Per decrease in the level0.50 (0.17-1.48)≤0.213
Spleen size (cm)Per cm increase1.55 (1.21-1.98)≤0.001
Portal vein diameter (mm)Per mm increase1.1 (0.82-1.98)≤0.523
Stages of fibrosis:
(i) Mild to moderatePer increase in stage8.67 (0.96-77.96)≤0.05
(ii) Advanced fibrosis and cirrhosis